- Home
- LNW vs LEGN Comparison
LNW vs LEGN Comparison
Compare LNW & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNW
- LEGN
- Stock Information
- Founded
- LNW 1984
- LEGN 2014
- Country
- LNW United States
- LEGN United States
- Employees
- LNW N/A
- LEGN N/A
- Industry
- LNW EDP Services
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- LNW Technology
- LEGN Health Care
- Exchange
- LNW Nasdaq
- LEGN Nasdaq
- Market Cap
- LNW 6.9B
- LEGN 7.0B
- IPO Year
- LNW N/A
- LEGN 2020
- Fundamental
- Price
- LNW $79.96
- LEGN $32.80
- Analyst Decision
- LNW Buy
- LEGN Strong Buy
- Analyst Count
- LNW 12
- LEGN 12
- Target Price
- LNW $109.42
- LEGN $79.00
- AVG Volume (30 Days)
- LNW 1.1M
- LEGN 1.6M
- Earning Date
- LNW 05-07-2025
- LEGN 05-12-2025
- Dividend Yield
- LNW N/A
- LEGN N/A
- EPS Growth
- LNW 110.29
- LEGN N/A
- EPS
- LNW 3.68
- LEGN N/A
- Revenue
- LNW $3,188,000,000.00
- LEGN $627,241,000.00
- Revenue This Year
- LNW $8.88
- LEGN $66.92
- Revenue Next Year
- LNW $6.48
- LEGN $51.77
- P/E Ratio
- LNW $21.73
- LEGN N/A
- Revenue Growth
- LNW 9.86
- LEGN 119.97
- 52 Week Low
- LNW $75.46
- LEGN $29.27
- 52 Week High
- LNW $115.00
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- LNW 37.61
- LEGN 45.92
- Support Level
- LNW $77.07
- LEGN $29.27
- Resistance Level
- LNW $81.54
- LEGN $35.11
- Average True Range (ATR)
- LNW 4.75
- LEGN 1.89
- MACD
- LNW -0.46
- LEGN 0.16
- Stochastic Oscillator
- LNW 25.40
- LEGN 60.48
About LNW Light & Wonder Inc.
Light & Wonder is principally an electronic gaming machine manufacturer, selling machines to pubs, clubs, and casinos. The firm is licensed in most jurisdictions allowing gambling globally. Light & Wonder is one of the three largest players in the space along with International Game Technology and Aristocrat Leisure. SciPlay, about one fourth of revenue, develops and distributes casual mobile games, principally in the social casino niche. The more nascent iGaming business sits between these two businesses, providing digital content and capabilities to real-money gaming providers.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.